| Peer-Reviewed

Incidence, Predictors and Reasons of Attrition of Patients on Antiretroviral Therapy for HIV in Eight Large-Cohort Sites in Conakry

Received: 20 December 2022     Accepted: 6 January 2023     Published: 17 January 2023
Views:       Downloads:
Abstract

Introduction: The purpose of this study was to estimate the incidence of attrition (death and lost to follow-up) among patients living with HIV on ART and to identify key predictors of this attrition. It also described the reasons why some patients are lost to follow-up. Methods: This was a historical cohort study of patients living with HIV put on ART between January 1, 2015 and December 31, 2020 in 8 large cohort sites in Conakry. An additional cross-sectional survey in the form of an investigation was conducted to describe the final status of patients reported lost to follow-up by the sites, as well as to describe the reasons for their loss to follow-up. Kaplan Meier techniques were used to estimate cumulative incidence, and the multivariate Cox proportional model was used to identify predictors of attrition. Results: The cumulative incidence of attrition was 19.50 over a median follow-up time of 2.5 years, for an overall attrition rate of 7.79 years per 100 person-years. Factors significantly associated with attrition were: Age 15 - 24 years [aHR = 2.212; 95% CI (1.321 - 3.704)], age >35 years [aHR = 1.723; 95% CI (1.041 - 2.852)], viral load >100,000 copies/ml [aHR = 2.056; 95% CI (1.668 - 2.534)], patients not on the 3-month or 6-month appointment system [aHR = 3.031; 95% CI (2.603 - 3.531)]. Conclusion: This study showed that the incidence of attrition increases with increasing follow-up time. Investigation of lost to follow-up reduced the estimated number of patients considered lost to follow-up and increased the number of deaths that were previously underreported. A prospective mixed study including many more variables would allow a better understanding of the attrition phenomenon among people living with HIV on ART in Guinea.

Published in International Journal of HIV/AIDS Prevention, Education and Behavioural Science (Volume 9, Issue 1)
DOI 10.11648/j.ijhpebs.20230901.12
Page(s) 9-19
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Attrition, Reasons, Predictors, Antiretroviral Treatment, HIV/AIDS, Conakry

References
[1] Seifu W, Ali W, Meresa B. Predictors of loss to follow up among adult clients attending antiretroviral treatment at Karamara general hospital, Jigjiga town, Eastern Ethiopia, 2015: a retrospective cohort study. BMC Infect Dis. 18 juin 2018; 18 (1): 280.
[2] Dejen D, Jara D, Yeshanew F, Fentaw Z, Mengie Feleke T, Girmaw F, et al. Attrition and Its Predictors Among Adults Receiving First-Line Antiretroviral Therapy in Woldia Town Public Health Facilities, Northeast Ethiopia: A Retrospective Cohort Study. HIVAIDS Auckl NZ. 20 avr 2021; 13: 445-54.
[3] Kalinjuma AV, Glass TR, Weisser M, Myeya SJ, Kasuga B, Kisung’a Y, et al. Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania. J Int AIDS Soc. 3 mars 2020; 23 (3): e25460.
[4] Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, et al. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PloS One. 2018; 13 (1): e0188488.
[5] Luebbert J, Tweya H, Phiri S, Chaweza T, Mwafilaso J, Hosseinipour MC, et al. Virological Failure and Drug Resistance in Patients on Antiretroviral Therapy After Treatment Interruption in Lilongwe, Malawi. Clin Infect Dis. 1 août 2012; 55 (3): 441-8.
[6] Fuente-Soro L, López-Varela E, Augusto O, Bernardo EL, Sacoor C, Nhacolo A, et al. Loss to follow-up and opportunities for reengagement in HIV care in rural Mozambique. Medicine (Baltimore). 15 mai 2020; 99 (20): e20236.
[7] Alvarez-Uria G, Naik PK, Pakam R, Midde M. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action. 12 sept 2013; 6: 10.3402/gha.v6i0.21682.
[8] Kiwanuka J, Mukulu Waila J, Muhindo Kahungu M, Kitonsa J, Kiwanuka N. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda. PLoS ONE. 7 avr 2020; 15 (4): e0217606.
[9] Teshale AB, Tsegaye AT, Wolde HF. Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling. PLoS ONE. 24 janv 2020; 15 (1): e0227473.
[10] Assemie MA, Muchie KF, Ayele TA. Incidence and predictors of loss to follow up among HIV-infected adults at Pawi General Hospital, northwest Ethiopia: competing risk regression model. BMC Res Notes. 10 mai 2018; 11: 287.
[11] Programme national de lutte contre le Sida et les Hépatites. La Problématique des perdus de vue durant la Prise en Charge du VIH/Sida. 2019. [National AIDS and Hepatitis Control Program. The issue of lost to follow-up during HIV/AIDS Care. 2019].
[12] Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis. PLoS ONE. 4 juin 2009; 4 (6): e5790.
[13] Programme national de lutte contre le Sida et les Hépatites. Etude sur les capacités organisationnelles et fonctionnelles de 29 sites de prise en charge du VIH à grandes cohortes en Guinée. 2019. [National AIDS and Hepatitis Control Program. Study on the organizational and functional capacities of 29 large cohort HIV care sites in Guinee. 2019].
[14] Programme national de lutte contre le Sida et les Hépatites. Modèle simplifié reproductible (MSR). 2020. [National AIDS and Hepatitis Program. Simplified repliable model (SRM). 2020].
[15] Programme National de Prise en Charge Sanitaire et de Prévention des IST/VIH/SIDA de la Guinée. Normes et protocoles de prise en charge de l’infection par le VIH chez l’adulte et l’enfant en Guinée. Draft1 2008. https://www.who.int/hiv/pub/guidelines/guinea_art.pdf. [Guinea's National STI/HIV/AIDS Management and Prevention Program. Standards and protocols for the management of HIV infection in adults and children in Guinea. Draft1 2008. https://www.who.int/hiv/pub/guidelines/guinea_art.pdf].
[16] Tabatabai J, Namakhoma I, Tweya H, Phiri S, Schnitzler P, Neuhann F. Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi. Glob Health Action. 30 sept 2014; 7: 10.3402/gha. v7.24795.
Cite This Article
  • APA Style

    Niouma Nestor Leno, Jean Michel Lamah, Foromo Guilavogui, Thierno Saidou Diallo, Youssouf Koita, et al. (2023). Incidence, Predictors and Reasons of Attrition of Patients on Antiretroviral Therapy for HIV in Eight Large-Cohort Sites in Conakry. International Journal of HIV/AIDS Prevention, Education and Behavioural Science, 9(1), 9-19. https://doi.org/10.11648/j.ijhpebs.20230901.12

    Copy | Download

    ACS Style

    Niouma Nestor Leno; Jean Michel Lamah; Foromo Guilavogui; Thierno Saidou Diallo; Youssouf Koita, et al. Incidence, Predictors and Reasons of Attrition of Patients on Antiretroviral Therapy for HIV in Eight Large-Cohort Sites in Conakry. Int. J. HIV/AIDS Prev. Educ. Behav. Sci. 2023, 9(1), 9-19. doi: 10.11648/j.ijhpebs.20230901.12

    Copy | Download

    AMA Style

    Niouma Nestor Leno, Jean Michel Lamah, Foromo Guilavogui, Thierno Saidou Diallo, Youssouf Koita, et al. Incidence, Predictors and Reasons of Attrition of Patients on Antiretroviral Therapy for HIV in Eight Large-Cohort Sites in Conakry. Int J HIV/AIDS Prev Educ Behav Sci. 2023;9(1):9-19. doi: 10.11648/j.ijhpebs.20230901.12

    Copy | Download

  • @article{10.11648/j.ijhpebs.20230901.12,
      author = {Niouma Nestor Leno and Jean Michel Lamah and Foromo Guilavogui and Thierno Saidou Diallo and Youssouf Koita and Laye Kaba and Arnold Ahiatsi and Nagnouman Toure and Souleymane Chaloub and Andre Kamano and Mahamadou Drabo and Jean Gaudart},
      title = {Incidence, Predictors and Reasons of Attrition of Patients on Antiretroviral Therapy for HIV in Eight Large-Cohort Sites in Conakry},
      journal = {International Journal of HIV/AIDS Prevention, Education and Behavioural Science},
      volume = {9},
      number = {1},
      pages = {9-19},
      doi = {10.11648/j.ijhpebs.20230901.12},
      url = {https://doi.org/10.11648/j.ijhpebs.20230901.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijhpebs.20230901.12},
      abstract = {Introduction: The purpose of this study was to estimate the incidence of attrition (death and lost to follow-up) among patients living with HIV on ART and to identify key predictors of this attrition. It also described the reasons why some patients are lost to follow-up. Methods: This was a historical cohort study of patients living with HIV put on ART between January 1, 2015 and December 31, 2020 in 8 large cohort sites in Conakry. An additional cross-sectional survey in the form of an investigation was conducted to describe the final status of patients reported lost to follow-up by the sites, as well as to describe the reasons for their loss to follow-up. Kaplan Meier techniques were used to estimate cumulative incidence, and the multivariate Cox proportional model was used to identify predictors of attrition. Results: The cumulative incidence of attrition was 19.50 over a median follow-up time of 2.5 years, for an overall attrition rate of 7.79 years per 100 person-years. Factors significantly associated with attrition were: Age 15 - 24 years [aHR = 2.212; 95% CI (1.321 - 3.704)], age >35 years [aHR = 1.723; 95% CI (1.041 - 2.852)], viral load >100,000 copies/ml [aHR = 2.056; 95% CI (1.668 - 2.534)], patients not on the 3-month or 6-month appointment system [aHR = 3.031; 95% CI (2.603 - 3.531)]. Conclusion: This study showed that the incidence of attrition increases with increasing follow-up time. Investigation of lost to follow-up reduced the estimated number of patients considered lost to follow-up and increased the number of deaths that were previously underreported. A prospective mixed study including many more variables would allow a better understanding of the attrition phenomenon among people living with HIV on ART in Guinea.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Incidence, Predictors and Reasons of Attrition of Patients on Antiretroviral Therapy for HIV in Eight Large-Cohort Sites in Conakry
    AU  - Niouma Nestor Leno
    AU  - Jean Michel Lamah
    AU  - Foromo Guilavogui
    AU  - Thierno Saidou Diallo
    AU  - Youssouf Koita
    AU  - Laye Kaba
    AU  - Arnold Ahiatsi
    AU  - Nagnouman Toure
    AU  - Souleymane Chaloub
    AU  - Andre Kamano
    AU  - Mahamadou Drabo
    AU  - Jean Gaudart
    Y1  - 2023/01/17
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijhpebs.20230901.12
    DO  - 10.11648/j.ijhpebs.20230901.12
    T2  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
    JF  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
    JO  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
    SP  - 9
    EP  - 19
    PB  - Science Publishing Group
    SN  - 2575-5765
    UR  - https://doi.org/10.11648/j.ijhpebs.20230901.12
    AB  - Introduction: The purpose of this study was to estimate the incidence of attrition (death and lost to follow-up) among patients living with HIV on ART and to identify key predictors of this attrition. It also described the reasons why some patients are lost to follow-up. Methods: This was a historical cohort study of patients living with HIV put on ART between January 1, 2015 and December 31, 2020 in 8 large cohort sites in Conakry. An additional cross-sectional survey in the form of an investigation was conducted to describe the final status of patients reported lost to follow-up by the sites, as well as to describe the reasons for their loss to follow-up. Kaplan Meier techniques were used to estimate cumulative incidence, and the multivariate Cox proportional model was used to identify predictors of attrition. Results: The cumulative incidence of attrition was 19.50 over a median follow-up time of 2.5 years, for an overall attrition rate of 7.79 years per 100 person-years. Factors significantly associated with attrition were: Age 15 - 24 years [aHR = 2.212; 95% CI (1.321 - 3.704)], age >35 years [aHR = 1.723; 95% CI (1.041 - 2.852)], viral load >100,000 copies/ml [aHR = 2.056; 95% CI (1.668 - 2.534)], patients not on the 3-month or 6-month appointment system [aHR = 3.031; 95% CI (2.603 - 3.531)]. Conclusion: This study showed that the incidence of attrition increases with increasing follow-up time. Investigation of lost to follow-up reduced the estimated number of patients considered lost to follow-up and increased the number of deaths that were previously underreported. A prospective mixed study including many more variables would allow a better understanding of the attrition phenomenon among people living with HIV on ART in Guinea.
    VL  - 9
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Public Health, Faculty of Health Sciences and Techniques, Gamal Abdel Nasser University of Conakry, Conakry, Guinea

  • National AIDS and Hepatitis Control Program, Conakry, Guinea

  • African Center of Excellence for Prevention and Control of Communicable Diseases (CEA-PCMT), Faculty of Health Sciences and Techniques, Gamal Abdel Nasser University of Conakry, Conakry, Guinea

  • National AIDS and Hepatitis Control Program, Conakry, Guinea

  • National AIDS and Hepatitis Control Program, Conakry, Guinea

  • National AIDS and Hepatitis Control Program, Conakry, Guinea

  • National AIDS and Hepatitis Control Program, Conakry, Guinea

  • National AIDS and Hepatitis Control Program, Conakry, Guinea

  • NGO Doctors Without Borders of Belgium, Conakry, Guinea

  • NGO Doctors Without Borders of Belgium, Conakry, Guinea

  • Faculty of Medicine, University of Aix Marseille, Marseille, France

  • Faculty of Medicine, University of Aix Marseille, Marseille, France

  • Sections